Well it was just one of those days. Zero for three so I closed shop and went out to enjoy the day. I followed the plan and was stopped out on all three trades. Losses were cut...(read more
Hapoalim Securities raised its price target on Nektar Therapeutics (NASDAQ: NKTR) to $19 from $16. It is reiterating its Buy rating on shares.
In a note to clients, Hapoalim writes, "After the impressive Phase II ovarian and breast...(read more
Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of cash.
Hospira Inc (NYSE: HSP) had $1.15 billion in total cash for the latest quarter. HSP's total debt stood at $2.24 billion in the same period.